TrialEpilepsia2020

Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.

Wyman W Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.